Skip to main content
Erschienen in: Investigational New Drugs 3/2020

03.07.2019 | PRECLINICAL STUDIES

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer

Erschienen in: Investigational New Drugs | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Summary

Background It is well-known that long-chain non-coding RNA (LncRNA) plays an important role in the development of tumor. DANCR, which is one crucial part of the lncRNA family, has been shown to be involved in the invasion of various tumors. However, its molecular mechanism in pancreatic cancer remains unknown. Methods qRT-PCR was used to detect the expression of DANCR, miR-135a mRNA in pancreatic cancer tissues or cells. E-cadherin and NLRP3 protein levels were measured by Western Blot. CCK-8, cell scratch, and transwell assays were applied to detect the proliferation and invasion of pancreatic cancer cells. Bioinformatical analysis and luciferase assay were performed to explore the relationship among DANCR, miR-135a and NLRP3. Results In pancreatic cancer, DANCR was up-regulated while miR-135a was down-regulated. The over-expression of DANCR promoted the proliferation and invasion of pancreatic cancer cells. A negative relationship was found between DANCR and miR-135a expression. Moreover, we found that miR-135a reversed the effects of DANCR in the promoting of pancreatic cancer cells, which was achieved by regulating the downstream protein of NLRP3. The correlations among DANCR, miR-135a and NLRP3 were confirmed in animal experiments. Conclusion DANCR promoted proliferation and invasion through the regulating of miR-135a / NLRP3 axis in pancreatic cancer cell. Our results suggest that DANCR may be a potential target for the therapy of pancreatic cancer.
Literatur
1.
Zurück zum Zitat Bray F, Ren JS, Masuyer E, Ferlay J (2013) "Global estimates of cancer prevalence for 27 sites in the adult population in 2008," (in eng). Int J Cancer, Research Support, Non-U.S. Gov't 132(5):1133–1145CrossRef Bray F, Ren JS, Masuyer E, Ferlay J (2013) "Global estimates of cancer prevalence for 27 sites in the adult population in 2008," (in eng). Int J Cancer, Research Support, Non-U.S. Gov't 132(5):1133–1145CrossRef
2.
Zurück zum Zitat Ilic M, Ilic I (2016) "Epidemiology of pancreatic cancer," (in eng). World J Gastroenterol, Review 22(44):9694–9705CrossRef Ilic M, Ilic I (2016) "Epidemiology of pancreatic cancer," (in eng). World J Gastroenterol, Review 22(44):9694–9705CrossRef
3.
Zurück zum Zitat Ferlay J et al (2015) "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012," (in eng). Int J Cancer 136(5):E359–E386CrossRef Ferlay J et al (2015) "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012," (in eng). Int J Cancer 136(5):E359–E386CrossRef
4.
Zurück zum Zitat Kanda M et al (2012) "Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia," (in eng). Gastroenterology, Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't 142(4):730–733 e9CrossRef Kanda M et al (2012) "Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia," (in eng). Gastroenterology, Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't 142(4):730–733 e9CrossRef
5.
Zurück zum Zitat Bertone P et al (2004) "Global identification of human transcribed sequences with genome tiling arrays," (in eng). Science, Research Support, U.S. Gov't, P.H.S 306(5705):2242–2246CrossRef Bertone P et al (2004) "Global identification of human transcribed sequences with genome tiling arrays," (in eng). Science, Research Support, U.S. Gov't, P.H.S 306(5705):2242–2246CrossRef
6.
Zurück zum Zitat Zhang D, Xiong M, Xu C, Xiang P, Zhong X (2016) "Long noncoding RNAs: an overview," (in eng). Methods Mol Biol, Research Support, Non-US Gov't Review 1402:287–295CrossRef Zhang D, Xiong M, Xu C, Xiang P, Zhong X (2016) "Long noncoding RNAs: an overview," (in eng). Methods Mol Biol, Research Support, Non-US Gov't Review 1402:287–295CrossRef
7.
Zurück zum Zitat Bhan A, Mandal SS (2015) "LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer," (in eng). Biochim Biophys Acta, Research Support, NIH, Extramural Review 1856(1):151–164PubMedPubMedCentral Bhan A, Mandal SS (2015) "LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer," (in eng). Biochim Biophys Acta, Research Support, NIH, Extramural Review 1856(1):151–164PubMedPubMedCentral
8.
Zurück zum Zitat Zuo ZK et al (Feb 2017) "TGFbeta1-induced LncRNA UCA1 upregulation promotes gastric Cancer invasion and migration," (in eng). DNA Cell Biol 36(2):159–167CrossRef Zuo ZK et al (Feb 2017) "TGFbeta1-induced LncRNA UCA1 upregulation promotes gastric Cancer invasion and migration," (in eng). DNA Cell Biol 36(2):159–167CrossRef
9.
Zurück zum Zitat Ma X et al (Dec 2016) "DANCR acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma," (in eng). Anticancer Res 36(12):6389–6398CrossRef Ma X et al (Dec 2016) "DANCR acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma," (in eng). Anticancer Res 36(12):6389–6398CrossRef
10.
Zurück zum Zitat Jia J et al (2016) Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3, (in eng). Oncotarget 7(25):37868–37881CrossRef Jia J et al (2016) Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3, (in eng). Oncotarget 7(25):37868–37881CrossRef
11.
Zurück zum Zitat Yang ZY et al (2017) "LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression," (in eng). Cancer Biomark 18(1):95–104CrossRef Yang ZY et al (2017) "LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression," (in eng). Cancer Biomark 18(1):95–104CrossRef
12.
Zurück zum Zitat Liu Y, Zhang M, Liang L, Li J, Chen YX (2015) Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer," (in eng. Int J Clin Exp Pathol 8(9):11480–11484PubMedPubMedCentral Liu Y, Zhang M, Liang L, Li J, Chen YX (2015) Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer," (in eng. Int J Clin Exp Pathol 8(9):11480–11484PubMedPubMedCentral
13.
Zurück zum Zitat Jiang N et al (2017) "lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition," (in eng). Cancer Lett, Research Support, Non-US Gov't 405:46–55CrossRef Jiang N et al (2017) "lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition," (in eng). Cancer Lett, Research Support, Non-US Gov't 405:46–55CrossRef
14.
Zurück zum Zitat Li J, Zhou L (2018) "Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/beta-catenin signaling," (in eng). Biomed Pharmacother 102:602–607CrossRef Li J, Zhou L (2018) "Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/beta-catenin signaling," (in eng). Biomed Pharmacother 102:602–607CrossRef
15.
Zurück zum Zitat Voutsadakis IA (2016) "Epithelial-mesenchymal transition (EMT) and regulation of EMT factors by steroid nuclear receptors in breast Cancer: a review and in silico investigation," (in eng). J Clin Med, Review 5(1) Voutsadakis IA (2016) "Epithelial-mesenchymal transition (EMT) and regulation of EMT factors by steroid nuclear receptors in breast Cancer: a review and in silico investigation," (in eng). J Clin Med, Review 5(1)
16.
Zurück zum Zitat Voutsadakis IA (2012) "Ubiquitination and the ubiquitin-proteasome system as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer," (in eng). Tumour Biol, Review 33(4):897–910CrossRef Voutsadakis IA (2012) "Ubiquitination and the ubiquitin-proteasome system as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer," (in eng). Tumour Biol, Review 33(4):897–910CrossRef
17.
Zurück zum Zitat Pan L et al (2018) Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells," (in eng. Oncotarget 9(2):1915–1930CrossRef Pan L et al (2018) Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells," (in eng. Oncotarget 9(2):1915–1930CrossRef
18.
Zurück zum Zitat Lu QC, Rui ZH, Guo ZL, Xie W, Shan S, Ren T (2018) "LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression," (in eng). J Cell Mol Med 22(3):1527–1537CrossRef Lu QC, Rui ZH, Guo ZL, Xie W, Shan S, Ren T (2018) "LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression," (in eng). J Cell Mol Med 22(3):1527–1537CrossRef
19.
Zurück zum Zitat Pan HW, Li SC, Tsai KW (2013) "MicroRNA dysregulation in gastric cancer," (in eng). Curr Pharm Des, Research Support, Non-US Gov't Review 19(7):1273–1284PubMed Pan HW, Li SC, Tsai KW (2013) "MicroRNA dysregulation in gastric cancer," (in eng). Curr Pharm Des, Research Support, Non-US Gov't Review 19(7):1273–1284PubMed
Metadaten
Titel
LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer
Publikationsdatum
03.07.2019
Erschienen in
Investigational New Drugs / Ausgabe 3/2020
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-019-00798-0

Weitere Artikel der Ausgabe 3/2020

Investigational New Drugs 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.